C. Balmelli

发表

Utility of 14 novel biomarkers in patients with acute chest pain and undetectable levels of conventional cardiac troponin.

C. Wolf, R. Twerenbold, P. Haaf, 2013, International journal of cardiology.

Normal presenting levels of high-sensitivity troponin and myocardial infarction

R. Twerenbold, P. Haaf, J. Minners, 2013, Heart.

Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men.

C. Vilaplana, R. Twerenbold, P. Haaf, 2013, American heart journal.

Long-term tolerability of the BRAF inhibitor vemurafenib in patients with metastatic melanoma: current study data and real-life observations

A. Wicki, C. Monnerat, V. Spataro, 2014, memo - Magazine of European Medical Oncology.

Risk stratification in patients with unstable angina using absolute serial changes of 3 high-sensitive troponin assays.

R. Twerenbold, P. Haaf, C. Mueller, 2013, American heart journal.

Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis.

S. Kurz, R. Twerenbold, P. Haaf, 2012, The American journal of medicine.

How safe is the outpatient management of patients with acute chest pain and mildly increased cardiac troponin concentrations?

R. Twerenbold, A. Irfan, P. Haaf, 2012, Clinical chemistry.

High-sensitive troponin, B-type natriuretic peptide and coronary angiogram findings in patients with non ST-segment elevation acute coronary syndrome.

R. Twerenbold, A. Irfan, P. Haaf, 2011, International journal of cardiology.

Response to letters regarding article, "High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease".

K. Denhaerynck, R. Twerenbold, P. Haaf, 2013, Circulation.

Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma

M. Bossard, O. Pfister, A. Zippelius, 2015, Journal of Immunotherapy for Cancer.

Utile or futile: biomarkers in the ICU

C. Mueller, B. Drexler, C. Balmelli, 2011, Critical care.

[Fatal brain edema after ingestion of ecstasy and benzylpiperazine].

K. Rentsch, H. Kupferschmidt, M. Schneemann, 2001, Deutsche medizinische Wochenschrift.

One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T.

C. Schindler, R. Twerenbold, P. Haaf, 2012, Archives of internal medicine.

Pathophysiology of lower extremity edema in acute heart failure revisited.

C. Mueller, A. Irfan, C. Meune, 2012, The American journal of medicine.

Quantifying Cardiac Hemodynamic Stress and Cardiomyocyte Damage in Ischemic and Nonischemic Acute Heart Failure

M. Nieminen, C. Mueller, P. Haaf, 2012, Circulation. Heart failure.

[Schoenlein-Henoch purpura: course in 139 children].

M. Bianchetti, C. Balmelli, R. Laux-End, 1996, Schweizerische medizinische Wochenschrift.

Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.

C. Wolf, R. Twerenbold, A. Irfan, 2012, The American journal of cardiology.

Heart failure therapy-induced early ST2 changes may offer long-term therapy guidance.

P. Benkert, C. Mueller, R. Twerenbold, 2013, Journal of cardiac failure.

N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.

R. Twerenbold, P. Haaf, C. Meune, 2011, The American journal of medicine.

Patients with acute coronary syndrome and normal high-sensitivity troponin.

R. Twerenbold, A. Irfan, P. Haaf, 2011, The American journal of medicine.

Mid-regional pro-adrenomedullin in the early evaluation of acute chest pain patients.

R. Twerenbold, A. Irfan, P. Haaf, 2013, International journal of cardiology.

Uric acid for diagnosis and risk stratification in suspected myocardial infarction

C. Vilaplana, R. Twerenbold, P. Haaf, 2013, European journal of clinical investigation.

Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction

R. Twerenbold, P. Haaf, S. Bassetti, 2012, Heart.

Use of copeptin and high-sensitive cardiac troponin T for diagnosis and prognosis in patients with diabetes mellitus and suspected acute myocardial infarction.

C. Vilaplana, R. Twerenbold, P. Haaf, 2015, International journal of cardiology.

High-Sensitivity Cardiac Troponin in the Distinction of Acute Myocardial Infarction From Acute Cardiac Noncoronary Artery Disease

K. Denhaerynck, R. Twerenbold, P. Haaf, 2012, Circulation.

Utility of C-terminal proendothelin in the early diagnosis and risk stratification of patients with suspected acute myocardial infarction.

R. Twerenbold, P. Haaf, C. Mueller, 2014, The Canadian journal of cardiology.

Consideration of high-sensitivity troponin values below the 99th percentile at presentation: does it improve diagnostic accuracy?

R. Twerenbold, P. Haaf, C. Meune, 2013, International journal of cardiology.

Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays.

J. Gea, R. Twerenbold, P. Haaf, 2012, European heart journal.

AJM onlineLetterThe Reply

P. Haaf, C. Mueller, C. Balmelli, 2012 .

Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction

R. Twerenbold, P. Haaf, S. Bassetti, 2012, Heart.

Normal presenting levels of high-sensitivity troponin and myocardial infarction

R. Twerenbold, P. Haaf, J. Minners, 2013, Heart.

Patients with acute coronary syndrome and normal high-sensitivity troponin.

R. Twerenbold, P. Haaf, S. Bassetti, 2011, The American journal of medicine.